Dennis Hom
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/05/2024
Storia della carriera di Dennis Hom
Precedenti posizioni note di Dennis Hom
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SAGIMET BIOSCIENCES INC. | Direttore Finanziario/CFO | 01/10/2017 | 01/08/2023 |
| ACHAOGEN | Direttore Finanziario/CFO | 01/01/2013 | 31/03/2014 |
| Contatto Relazioni con gli Investitori | 01/01/2013 | 31/03/2014 | |
| Public Communications Contact | 01/01/2013 | 31/03/2014 | |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2012 |
Formazione di Dennis Hom
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director of Finance/CFO | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Settori
| Health Technology | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Dennis Hom
- Esperienza
